Singapore markets closed

Stagwell Inc. (STGW)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.12+0.38 (+5.60%)
As of 11:45AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 797.88M
Enterprise value 2.27B
Trailing P/E 52.94
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.30
Price/book (mrq)2.36
Enterprise value/revenue 0.90
Enterprise value/EBITDA 5.67

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 318.04%
S&P500 52-week change 323.57%
52-week high 38.59
52-week low 33.83
50-day moving average 35.84
200-day moving average 35.64

Share statistics

Avg vol (3-month) 3571.88k
Avg vol (10-day) 3631.58k
Shares outstanding 5118.38M
Implied shares outstanding 6151.65M
Float 8105.3M
% held by insiders 14.13%
% held by institutions 197.34%
Shares short (15 Apr 2024) 44.84M
Short ratio (15 Apr 2024) 48.78
Short % of float (15 Apr 2024) 48.78%
Short % of shares outstanding (15 Apr 2024) 44.13%
Shares short (prior month 15 Mar 2024) 44.96M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 324 Aug 2016
Ex-dividend date 4N/A
Last split factor 23:2
Last split date 329 Nov 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -0.10%
Operating margin (ttm)4.08%

Management effectiveness

Return on assets (ttm)2.05%
Return on equity (ttm)4.98%

Income statement

Revenue (ttm)2.57B
Revenue per share (ttm)21.73
Quarterly revenue growth (yoy)7.70%
Gross profit (ttm)N/A
EBITDA 270.44M
Net income avi to common (ttm)-2.54M
Diluted EPS (ttm)-0.01
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)129.82M
Total cash per share (mrq)1.11
Total debt (mrq)1.6B
Total debt/equity (mrq)198.41%
Current ratio (mrq)0.83
Book value per share (mrq)2.85

Cash flow statement

Operating cash flow (ttm)113M
Levered free cash flow (ttm)208.26M